PL4303211T3 - Przemysłowy sposób wytwarzania estru (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7- (etyloamino)-7-okso-2-hepten-1-ylo]-3,5-dihydroksycyklopentylo]-1-(2-fenyloetylo)-2- propen-1-ylowego kwasu 6-(nitrooksy)heksanowego i produktu o wysokiej czystości - Google Patents

Przemysłowy sposób wytwarzania estru (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7- (etyloamino)-7-okso-2-hepten-1-ylo]-3,5-dihydroksycyklopentylo]-1-(2-fenyloetylo)-2- propen-1-ylowego kwasu 6-(nitrooksy)heksanowego i produktu o wysokiej czystości

Info

Publication number
PL4303211T3
PL4303211T3 PL22290046.6T PL22290046T PL4303211T3 PL 4303211 T3 PL4303211 T3 PL 4303211T3 PL 22290046 T PL22290046 T PL 22290046T PL 4303211 T3 PL4303211 T3 PL 4303211T3
Authority
PL
Poland
Prior art keywords
dihydroxycyclopentyl
nitrooxy
hepten
propen
ethylamino
Prior art date
Application number
PL22290046.6T
Other languages
English (en)
Inventor
Szabolcs Kovács
Andrea SÁNTÁNÉ CSUTOR
Irén HORTOBÁGYI
Judit PÓTI
Gael Ronsin
Nicoletta Almirante
Original Assignee
Nicox S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox S.A. filed Critical Nicox S.A.
Publication of PL4303211T3 publication Critical patent/PL4303211T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C07C231/24—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2531/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • C07C2531/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL22290046.6T 2022-07-07 2022-07-07 Przemysłowy sposób wytwarzania estru (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7- (etyloamino)-7-okso-2-hepten-1-ylo]-3,5-dihydroksycyklopentylo]-1-(2-fenyloetylo)-2- propen-1-ylowego kwasu 6-(nitrooksy)heksanowego i produktu o wysokiej czystości PL4303211T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP22290046.6A EP4303211B1 (en) 2022-07-07 2022-07-07 Industrial process for the preparation of hexanoic acid, 6(nitrooxy)-,(1s,2e)-3-[(1r,2r,3s,5r)-2-[(2z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]3,5-dihydroxycyclopentyl]-1-(2-phenyl ethyl)-2-propen-1-yl ester and high pure product

Publications (1)

Publication Number Publication Date
PL4303211T3 true PL4303211T3 (pl) 2024-12-16

Family

ID=82850340

Family Applications (1)

Application Number Title Priority Date Filing Date
PL22290046.6T PL4303211T3 (pl) 2022-07-07 2022-07-07 Przemysłowy sposób wytwarzania estru (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7- (etyloamino)-7-okso-2-hepten-1-ylo]-3,5-dihydroksycyklopentylo]-1-(2-fenyloetylo)-2- propen-1-ylowego kwasu 6-(nitrooksy)heksanowego i produktu o wysokiej czystości

Country Status (23)

Country Link
US (2) US20240018096A1 (pl)
EP (3) EP4303211B1 (pl)
JP (2) JP2024012261A (pl)
KR (1) KR20250034143A (pl)
CN (2) CN119522211A (pl)
AR (1) AR129847A1 (pl)
AU (1) AU2023303861A1 (pl)
CA (1) CA3261164A1 (pl)
DK (1) DK4303211T3 (pl)
ES (1) ES2992696T3 (pl)
FI (1) FI4303211T3 (pl)
HR (1) HRP20241504T1 (pl)
HU (1) HUE069026T2 (pl)
LT (1) LT4303211T (pl)
MA (2) MA65191B1 (pl)
MX (1) MX2025000209A (pl)
PL (1) PL4303211T3 (pl)
PT (1) PT4303211T (pl)
RS (1) RS66198B1 (pl)
SI (1) SI4303211T1 (pl)
SM (1) SMT202400481T1 (pl)
TW (1) TW202408995A (pl)
WO (1) WO2024008844A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2964005T3 (es) * 2019-08-05 2024-04-03 Nicox Sa Procedimiento de preparación de un análogo de prostaglandina donador de óxido nítrico

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR076731A1 (es) * 2008-05-09 2011-07-06 Pfizer Prostamidas donadoras de oxido nitrico, uso de los mismos y composiciones farmaceuticas
ES2836118T3 (es) * 2018-02-21 2021-06-24 Nicox Sa Procedimiento para la preparación de un análogo de prostaglandina donante de óxido nítrico
ES2964005T3 (es) * 2019-08-05 2024-04-03 Nicox Sa Procedimiento de preparación de un análogo de prostaglandina donador de óxido nítrico
US20240158345A1 (en) * 2021-02-03 2024-05-16 Nicox S.A. Process for the preparation of a nitric oxide donating prostaglandin analogue

Also Published As

Publication number Publication date
AR129847A1 (es) 2024-10-02
RS66198B1 (sr) 2024-12-31
EP4303211A1 (en) 2024-01-10
EP4303211B1 (en) 2024-08-21
MA71652A (fr) 2025-05-30
HRP20241504T1 (hr) 2025-01-03
US20250320182A1 (en) 2025-10-16
EP4551553A1 (en) 2025-05-14
MX2025000209A (es) 2025-02-10
JP2024012261A (ja) 2024-01-30
US20240018096A1 (en) 2024-01-18
HUE069026T2 (hu) 2025-02-28
CN117362210A (zh) 2024-01-09
CA3261164A1 (en) 2024-01-11
TW202408995A (zh) 2024-03-01
AU2023303861A1 (en) 2025-02-20
KR20250034143A (ko) 2025-03-10
ES2992696T3 (en) 2024-12-17
MA65191B1 (fr) 2024-10-31
EP4410294A3 (en) 2024-11-06
FI4303211T3 (fi) 2024-11-21
LT4303211T (lt) 2024-11-25
EP4410294A2 (en) 2024-08-07
WO2024008844A1 (en) 2024-01-11
DK4303211T3 (da) 2024-10-07
SMT202400481T1 (it) 2025-01-14
SI4303211T1 (sl) 2025-01-31
CN119522211A (zh) 2025-02-25
JP2025523301A (ja) 2025-07-18
PT4303211T (pt) 2024-11-18

Similar Documents

Publication Publication Date Title
EA201391251A1 (ru) ПРОИЗВОДНЫЕ 6,7-ДИГИДРОПИРАЗОЛО[1,5-a]ПИРАЗИН-4-ИЛАМИНА, ПРИГОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ БЕТА-СЕКРЕТАЗЫ (BACE)
EA201391296A1 (ru) ПРОИЗВОДНЫЕ 3,4-ДИГИДРОПИРРОЛО[1,2-a]ПИРАЗИН-1-ИЛАМИНА, ПРИГОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ БЕТА-СЕКРЕТАЗЫ (BACE)
MA44721A (fr) Inhibiteurs de mcl1 macrocycliques pour le traitement du cancer
EA201301019A1 (ru) Бензодиоксановые ингибиторы продуцирования лейкотриена
HK1215256A1 (zh) 用作吲哚胺2，3-二氧化酶的抑制劑的化合物
WO2013126990A8 (en) Method for the preparation of triglycerides of medium-chain length fatty acids
MA29311B1 (fr) Derives d'isoxazolines et son nouveau procede de production
EA201591093A1 (ru) Способы синтеза аналога простациклина
WO2016164763A8 (en) Compositions and methods for treating cns disorders
EA201491116A1 (ru) Производные 6-дифторметил-5,6-дигидро-2h-[1,4]оксазин-3-амина
MX2023007091A (es) Composiciones oftalmicas que contienen una prostamida liberadora de oxido nitrico.
PH12020551320A1 (en) Process for the preparation of a nitric oxide donating prostaglandin analogue
WO2012029077A3 (en) Process for preparing fluticasone propionate/furoate
CA3261164A1 (en) INDUSTRIAL PROCESS FOR THE PREPARATION OF HEXANOIC ACID, 6-(NITROOXY)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ETHYLAMINO)-7-OXO-2-HEPTEN-1-YL]-3,5-DIHYDROXYCYCLOPENTYL]-1-(2-PHENYLETHYL)-2-PROPEN-1-YL ESTER AND HIGH PURITY PRODUCT
WO2011112535A3 (en) Propionic acids, propionic acid esters, and related compounds
AR124724A1 (es) Proceso para la preparación de un análogo de prostaglandina donante de óxido nítrico
EP4110735A4 (en) PROCESS FOR THE PRODUCTION OF METHYLENE BLUE
JP4501690B2 (ja) ３，５−ジヒドロキシ−６−ヘプテン酸誘導体の製造方法
HUP2200363A1 (hu) Eljárás (1r,4r)-4-helyettesített ciklohexán-1-aminok elõállítására
IL288874A (en) [((5r,2s,1r)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-isopropyl acetic acid ester for the treatment of chronic cough
ES3065361T3 (en) Highly purified eicosapentaenoic acid, as free fatty acid for treatment of coronavirus-19 (covid-19)
AR120727A1 (es) Composición farmacéutica que comprende bpi-7711 y método de preparación de la misma
EP4393902A4 (en) PROCESS FOR THE PRODUCTION OF P-XYLENE
MA35509B1 (fr) Procede de synthese de derives de la 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one et application a la synthese de l'ivabradine.
TH2101000072A (th) องค์ประกอบที่ใช้เฉพาะที่กับตาซึ่งมีพรอสตาไมด์ที่ปลดปล่อยไนตริกออกไซด์